Home > News > Health News
Posted on Jan 21, 03:02PM | IBNS
Apollo Hospitals, India's leading healthcare provider, announced its plans to establish a Proton Therapy Center in India, the first of its kind across South East Asia, Africa and Australia.
"This launch that marks the beginning of the next wave of advancement in radiation therapy in India is worth approximately Rs. 400 crores, which covers the equipment and services supplied by IBA (Ion Beam Applications S.A.) to help establish the Apollo Proton Therapy Center including the long-term operation and maintenance contract," said an official release.
IBA is a cancer diagnostics and treatment company and the worldwide technology leader in the field of proton therapy.
Designed with state-of-the-art technology, IBA Proteus PLUS is clinically inspired to offer the possibility to configure the most appropriate combination of features to meet the individual needs of patients and provides a versatility to meet the clinical objectives of physicians.
IBA will equip the Apollo Proton Therapy Center with its Proteus PLUS multi-room configuration which will include three treatment rooms with Uniform Scanning and Pencil Beam Scanning capabilities.
IBA will also provide all dosimetry equipment to ensure the safest and fastest commissioning of the center so that patients can benefit from this technology starting 2016.
In addition to this, the Apollo Proton Therapy Center will have a significant portion of the facility dedicated to research and development that will partner with leading institutions across the world to foster innovation so as to make modern healthcare accessible and available for the nation.
Speaking on this new initiative, Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group, said, "This new proton therapy facility will give patients access to the most advanced radiation therapy technology.
"Moreover, the center will become an International Proton Therapy Center of Reference in Asia, allowing us to further enhance our ability to provide superior cancer care and promote the benefits of proton therapy technology across the sub-continent."
Olivier Legrain, Chief Executive Officer of IBA, commented: "The Indian healthcare market is growing rapidly and there is a significant need for innovative approaches to cancer therapy."
With approximately 3 million people suffering from cancer in India and one million new cases being detected every year, there is a need for specialty cancer treatment hospitals.
As most patients are diagnosed with advanced stage cancer, the demand for state-of-the-art cancer treatment is high.
This Proton Therapy Center, with its highly advanced technology, will be able to provide the best in class treatment for patients who suffer from cancer.
Proton therapy is increasingly considered the most advanced and targeted cancer treatment due to its superior dose distribution and fewer side effects.
Protons deposit the majority of their effective energy within a precisely controlled range, directly within the tumor and sparing healthy surrounding tissue.
It is used today to treat many cancers and is particularly appropriate in situations where treatment options are limited and conventional radiation therapy presents risks to patients.
These situations include eye and brain cancers, tumors close to the brain stem and spinal cord, prostate, liver, lung and breast cancers, and pediatric cancers.